AzTrials
AzTrials

Interprofessional RelationsSCOP3 qualiNCT03171779

Impact of Interprofessional Training and Co-ordination on Early Identification and Proactive Approach to End-of-life Situations in the Context of Primary Care

An observational study of Interprofessional Relations and End-of-life Situations, run by Centre Hospitalier Universitaire, Amiens at 1 site in France.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

More than 300,000 people die each year in France from a disease that may require palliative care. Nevertheless, only a small proportion of these patients are able to access this care, in particular because of a too late identification. Read more about this study

Who is it for?
Any age
What is being tested?
Patients approaching the end of their lives
How many people
58 participants
Where
1 siteFrance
Study dates
17 Jun 2015to 18 Oct 2027
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: Being a multi-professional health care home (MSP)

Who may be able to join

  • Being a multi-professional health care home (MSP)
  • At least one specialized palliative care resource available in the MSP territory (USP, EMSP, palliative care network)

Who cannot join

  • Health centers, group medical practices, clinics
  • Less than 3 general practitioners (GPs) and / or absence of nurses (FDI) within the MSP

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

France1 site, 1 recruiting
  • CHU Amiens Picardie

    Amiens, Picardie, 80054

    Maxime GIGNON, Dr, +33322667606, gignon.maxime@chu-amiens.fr

    Recruiting

Other trials in France

About this study

More than 300,000 people die each year in France from a disease that may require palliative care. Nevertheless, only a small proportion of these patients are able to access this care, in particular because of a too late identification.

While several factors may hinder access to specialized palliative care resources, one of the major barriers to the initiation of palliative care, and particularly to the implementation of quality end-of-life care, Remains the failure to recognize that patients with advanced chronic illness are actually approaching the end of their lives.

Read more

However, it is now clearly established that early integration of palliative care in the care of people living with a serious, incurable and progressive disease:

  • has an impact on the quality (and sometimes the expectation) of life of these people,
  • avoids aggressive treatments and unplanned hospitalizations,
  • is associated with lower health costs than other end-of-life patients. Primary health care providers have a major role to play in facilitating access to palliative care, but their practice has been hampered in our country by the fragmented and poorly coordinated nature of primary care and Negligible in terms of training. However, they remain the first contact of the patients with the system of care, and are also structuring for the continuation of the patient's journey within the health system.

The first hypothesis is that the work of genuine interprofessional primary care teams in multi-professional health centers (MSPs), coupled with adequate training in the use of simple tools, can contribute to the early identification of patients approaching End of life, to meet their palliative care needs.

However, various European programs (Gold Standards Framework in the UK, NECPAL in Catalonia, RADPAC in the Netherlands) have shown that identification alone is not enough to increase access to specialized palliative care. The second hypothesis is that it must be articulated for this with a training of the professionals to carry out conversations of anticipated planning of the care with their patients.

Being tested
Patients approaching the end of their lives

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Patients approaching the end of their livesOther

    To determine whether the use of simple tools by a primary care team for the early identification of end-of-life patients can improve access to specialized palliative care resources

Study groups in NCT03171779
Study groupRoleWhat they receive
Usual practiceNot described
Receives: Other: Patients approaching the end of their lives
IPEMInterprofessional Training in Early Identification and Multidimensional Evaluation (IPEM) of patients' palliative needs
Receives: Other: Patients approaching the end of their lives
IPEM and PASInterprofessional Early Identification Training and Multidimensional Assessment (IPEM) of patients' palliative needs, and to the Early Care Planning (SAP)
Receives: Other: Patients approaching the end of their lives

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Proportion of patients who have died from a condition that may require palliative care

    Proportion of patients who have died from a condition that may require palliative care

    Measured: 3 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted31 May 2017
  2. Study start17 Jun 2015
  3. Primary completion18 Oct 2027 (estimated)
  4. Study completion18 Oct 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
58 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03171779
Sponsor's protocol ID
PI2015_843_0038
Acronym
SCOP3 quali
Status last verified
Mar 2025
First submitted
29 May 2017
Last updated
2 Apr 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Interprofessional Relations and End-of-life Situations, run by Centre Hospitalier Universitaire, Amiens at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 2 Apr 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Maxime GIGNON, Dr (+33322667606, gignon.maxime@chu-amiens.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Proportion of patients who have died from a condition that may require palliative care (time frame: 3 years). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Apr 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in